Asset Management
Compare Stocks
5 / 10Stock Comparison
NEWT vs HONE vs BYFC vs CARV vs MFIN
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Financial - Credit Services
NEWT vs HONE vs BYFC vs CARV vs MFIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Asset Management | Banks - Regional | Banks - Regional | Banks - Regional | Financial - Credit Services |
| Market Cap | $394M | $522M | $92M | $9M | $225M |
| Revenue (TTM) | $322M | $314M | $63M | $37M | $353M |
| Net Income (TTM) | $61M | $26M | $-25M | $-13M | $47M |
| Gross Margin | 75.3% | 50.9% | 51.9% | 56.3% | 96.7% |
| Operating Margin | 42.5% | 10.9% | -38.8% | -36.8% | 50.5% |
| Forward P/E | 5.9x | 13.3x | — | — | 8.0x |
| Total Debt | $823M | $517M | $153M | $29M | $316M |
| Cash & Equiv. | $284M | $231M | $11M | $50M | $202M |
NEWT vs HONE vs BYFC vs CARV vs MFIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NewtekOne, Inc. (NEWT) | 100 | 79.7 | -20.3% |
| HarborOne Bancorp, … (HONE) | 100 | 151.8 | +51.8% |
| Broadway Financial … (BYFC) | 100 | 85.4 | -14.6% |
| Carver Bancorp, Inc. (CARV) | 100 | 93.8 | -6.2% |
| Medallion Financial… (MFIN) | 100 | 410.3 | +310.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEWT vs HONE vs BYFC vs CARV vs MFIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEWT carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 142.9% 10Y total return vs HONE's 88.3%
- PEG 0.72 vs HONE's 0.89
- Better valuation composite
- Efficiency ratio 0.3% vs CARV's 0.9% (lower = leaner)
HONE is the clearest fit if your priority is growth exposure.
- Rev growth 10.7%, EPS growth 78.4%
BYFC is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 2 yrs, beta 0.02, yield 3.5%
- Lower volatility, beta 0.02, Low D/E 58.1%, current ratio 0.03x
- Beta 0.02 vs NEWT's 1.69, lower leverage
- +52.8% vs HONE's +7.9%
Among these 5 stocks, CARV doesn't own a clear edge in any measured category.
MFIN ranks third and is worth considering specifically for defensive and bank quality.
- Beta 1.15, yield 4.7%, current ratio 27.10x
- NIM 7.3% vs HONE's 2.2%
- 21.1% NII/revenue growth vs CARV's -8.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.1% NII/revenue growth vs CARV's -8.3% | |
| Value | Better valuation composite | |
| Quality / Margins | Efficiency ratio 0.3% vs CARV's 0.9% (lower = leaner) | |
| Stability / Safety | Beta 0.02 vs NEWT's 1.69, lower leverage | |
| Dividends | 8.0% yield, 1-year raise streak, vs HONE's 2.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +52.8% vs HONE's +7.9% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CARV's 0.9% |
NEWT vs HONE vs BYFC vs CARV vs MFIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
NEWT vs HONE vs BYFC vs CARV vs MFIN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MFIN leads in 2 of 6 categories
NEWT leads 1 • BYFC leads 1 • HONE leads 0 • CARV leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MFIN leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MFIN is the larger business by revenue, generating $353M annually — 9.5x CARV's $37M. NEWT is the more profitable business, keeping 18.8% of every revenue dollar as net income compared to BYFC's -39.3%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $322M | $314M | $63M | $37M | $353M |
| EBITDAEarnings before interest/tax | $96M | $37M | -$24M | -$10M | $111M |
| Net IncomeAfter-tax profit | $61M | $26M | -$25M | -$13M | $47M |
| Free Cash FlowCash after capex | -$405M | $46M | -$13,000 | -$9M | $126M |
| Gross MarginGross profit ÷ Revenue | +75.3% | +50.9% | +51.9% | +56.3% | +96.7% |
| Operating MarginEBIT ÷ Revenue | +42.5% | +10.9% | -38.8% | -36.8% | +50.5% |
| Net MarginNet income ÷ Revenue | +18.8% | +8.7% | -39.3% | -36.8% | +12.2% |
| FCF MarginFCF ÷ Revenue | +17.3% | +0.8% | -0.0% | -34.6% | +35.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +11.8% | +11.1% | -46.8% | -12.2% | +16.3% |
Valuation Metrics
Evenly matched — NEWT and CARV and MFIN each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 5.4x trailing earnings, MFIN trades at a 71% valuation discount to HONE's 18.3x P/E. Adjusting for growth (PEG ratio), NEWT offers better value at 0.70x vs HONE's 1.23x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $394M | $522M | $92M | $9M | $225M |
| Enterprise ValueMkt cap + debt − cash | $933M | $808M | $234M | -$12M | $340M |
| Trailing P/EPrice ÷ TTM EPS | 5.79x | 18.33x | -3.05x | -0.63x | 5.37x |
| Forward P/EPrice ÷ next-FY EPS est. | 5.93x | 13.30x | — | — | 7.97x |
| PEG RatioP/E ÷ EPS growth rate | 0.70x | 1.23x | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.79x | 20.84x | — | — | 1.90x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 1.66x | 1.45x | 0.24x | 0.64x |
| Price / BookPrice ÷ Book value/share | 0.88x | 0.87x | 0.32x | 0.29x | 0.46x |
| Price / FCFMarket cap ÷ FCF | 7.05x | 200.70x | — | — | 1.78x |
Profitability & Efficiency
NEWT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
NEWT delivers a 17.3% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-48 for CARV. BYFC carries lower financial leverage with a 0.58x debt-to-equity ratio, signaling a more conservative balance sheet compared to NEWT's 2.07x. On the Piotroski fundamental quality scale (0–9), MFIN scores 7/9 vs CARV's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +17.3% | +4.6% | -9.1% | -48.4% | +9.4% |
| ROA (TTM)Return on assets | +2.6% | +0.5% | -1.9% | -1.9% | +1.6% |
| ROICReturn on invested capital | +9.2% | +2.3% | -3.7% | -13.0% | +17.2% |
| ROCEReturn on capital employed | +13.6% | +3.5% | -5.6% | -15.4% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 2 | 7 |
| Debt / EquityFinancial leverage | 2.07x | 0.90x | 0.58x | 0.98x | 0.62x |
| Net DebtTotal debt minus cash | $539M | $285M | $142M | -$21M | $115M |
| Cash & Equiv.Liquid assets | $284M | $231M | $11M | $50M | $202M |
| Total DebtShort + long-term debt | $823M | $517M | $153M | $29M | $316M |
| Interest CoverageEBIT ÷ Interest expense | 1.10x | 0.24x | -0.87x | -0.71x | 1.07x |
Total Returns (Dividends Reinvested)
MFIN leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MFIN five years ago would be worth $12,317 today (with dividends reinvested), compared to $2,074 for CARV. Over the past 12 months, BYFC leads with a +52.8% total return vs HONE's +7.9%. The 3-year compound annual growth rate (CAGR) favors MFIN at 16.7% vs CARV's -27.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.3% | — | +29.3% | +19.3% | -4.9% |
| 1-Year ReturnPast 12 months | +45.6% | +7.9% | +52.8% | +18.4% | +8.2% |
| 3-Year ReturnCumulative with dividends | +35.4% | +58.9% | +30.9% | -61.3% | +58.9% |
| 5-Year ReturnCumulative with dividends | -23.2% | -5.8% | -33.2% | -79.3% | +23.2% |
| 10-Year ReturnCumulative with dividends | +142.9% | +88.3% | -37.6% | -53.6% | +60.3% |
| CAGR (3Y)Annualised 3-year return | +10.6% | +16.7% | +9.4% | -27.2% | +16.7% |
Risk & Volatility
BYFC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BYFC is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than NEWT's 1.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BYFC currently trades 99.8% from its 52-week high vs CARV's 43.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.69x | 1.05x | 0.02x | 0.08x | 1.15x |
| 52-Week HighHighest price in past year | $14.91 | $14.29 | $9.86 | $3.85 | $11.00 |
| 52-Week LowLowest price in past year | $9.59 | $10.57 | $5.60 | $1.07 | $7.88 |
| % of 52W HighCurrent price vs 52-week peak | +91.7% | +84.7% | +99.8% | +43.4% | +86.9% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 32.5 | 75.4 | 50.2 | 55.0 |
| Avg Volume (50D)Average daily shares traded | 205K | 0 | 4K | 4K | 59K |
Analyst Outlook
Evenly matched — NEWT and HONE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NEWT as "Hold", HONE as "Hold", MFIN as "Hold". Consensus price targets imply 15.7% upside for HONE (target: $14) vs 2.4% for NEWT (target: $14). For income investors, NEWT offers the higher dividend yield at 8.00% vs HONE's 2.61%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | — | — | Hold |
| Price TargetConsensus 12-month target | $14.00 | $14.00 | — | — | — |
| # AnalystsCovering analysts | 9 | 6 | — | — | 9 |
| Dividend YieldAnnual dividend ÷ price | +8.0% | +2.6% | +3.5% | — | +4.7% |
| Dividend StreakConsecutive years of raises | 1 | 5 | 2 | 0 | 4 |
| Dividend / ShareAnnual DPS | $1.09 | $0.32 | $0.35 | — | $0.45 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +4.1% | 0.0% | 0.0% | +0.4% |
MFIN leads in 2 of 6 categories (Income & Cash Flow, Total Returns). NEWT leads in 1 (Profitability & Efficiency). 2 tied.
NEWT vs HONE vs BYFC vs CARV vs MFIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEWT or HONE or BYFC or CARV or MFIN a better buy right now?
For growth investors, Medallion Financial Corp.
(MFIN) is the stronger pick with 21. 1% revenue growth year-over-year, versus -8. 3% for Carver Bancorp, Inc. (CARV). Medallion Financial Corp. (MFIN) offers the better valuation at 5. 4x trailing P/E (8. 0x forward), making it the more compelling value choice. Analysts rate NewtekOne, Inc. (NEWT) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEWT or HONE or BYFC or CARV or MFIN?
On trailing P/E, Medallion Financial Corp.
(MFIN) is the cheapest at 5. 4x versus HarborOne Bancorp, Inc. at 18. 3x. On forward P/E, NewtekOne, Inc. is actually cheaper at 5. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NewtekOne, Inc. wins at 0. 72x versus HarborOne Bancorp, Inc. 's 0. 89x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NEWT or HONE or BYFC or CARV or MFIN?
Over the past 5 years, Medallion Financial Corp.
(MFIN) delivered a total return of +23. 2%, compared to -79. 3% for Carver Bancorp, Inc. (CARV). Over 10 years, the gap is even starker: NEWT returned +142. 9% versus CARV's -53. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEWT or HONE or BYFC or CARV or MFIN?
By beta (market sensitivity over 5 years), Broadway Financial Corporation (BYFC) is the lower-risk stock at 0.
02β versus NewtekOne, Inc. 's 1. 69β — meaning NEWT is approximately 6704% more volatile than BYFC relative to the S&P 500. On balance sheet safety, Broadway Financial Corporation (BYFC) carries a lower debt/equity ratio of 58% versus 2% for NewtekOne, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NEWT or HONE or BYFC or CARV or MFIN?
By revenue growth (latest reported year), Medallion Financial Corp.
(MFIN) is pulling ahead at 21. 1% versus -8. 3% for Carver Bancorp, Inc. (CARV). On earnings-per-share growth, the picture is similar: HarborOne Bancorp, Inc. grew EPS 78. 4% year-over-year, compared to -81. 8% for Broadway Financial Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEWT or HONE or BYFC or CARV or MFIN?
NewtekOne, Inc.
(NEWT) is the more profitable company, earning 18. 8% net margin versus -39. 3% for Broadway Financial Corporation — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFIN leads at 50. 5% versus -38. 8% for BYFC. At the gross margin level — before operating expenses — MFIN leads at 96. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEWT or HONE or BYFC or CARV or MFIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NewtekOne, Inc. (NEWT) is the more undervalued stock at a PEG of 0. 72x versus HarborOne Bancorp, Inc. 's 0. 89x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NewtekOne, Inc. (NEWT) trades at 5. 9x forward P/E versus 13. 3x for HarborOne Bancorp, Inc. — 7. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HONE: 15. 7% to $14. 00.
08Which pays a better dividend — NEWT or HONE or BYFC or CARV or MFIN?
In this comparison, NEWT (8.
0% yield), MFIN (4. 7% yield), BYFC (3. 5% yield), HONE (2. 6% yield) pay a dividend. CARV does not pay a meaningful dividend and should not be held primarily for income.
09Is NEWT or HONE or BYFC or CARV or MFIN better for a retirement portfolio?
For long-horizon retirement investors, Broadway Financial Corporation (BYFC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
02), 3. 5% yield). NewtekOne, Inc. (NEWT) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BYFC: -37. 6%, NEWT: +142. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEWT and HONE and BYFC and CARV and MFIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEWT is a small-cap deep-value stock; HONE is a small-cap quality compounder stock; BYFC is a small-cap income-oriented stock; CARV is a small-cap quality compounder stock; MFIN is a small-cap high-growth stock. NEWT, HONE, BYFC, MFIN pay a dividend while CARV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.